Introduction
============

Lumbar spinal stenosis results from progressive degenerative disease of the spinal canal, and is the most common spinal disorder in patients aged ≥60 years.[@b1-cia-13-1763]--[@b3-cia-13-1763] It typically presents with buttock or low back pain, sensory and motor disturbances in the lower leg, and neurogenic intermittent claudication.[@b4-cia-13-1763] Lumbar spinal stenosis is characterized by narrowing of the lumbar spinal canal, which is caused by facet joint hypertrophy, hypertrophy of the ligamentum flavum, mechanical compression of the lumbar spinal nerve roots, and disc herniation combined with osteophytes.[@b5-cia-13-1763],[@b6-cia-13-1763] Anatomically, degenerative lumbar spinal stenosis may involve the lumbar central canal spinal stenosis (LCCSS), the foramina, the extraforaminal zone, or a combination of these locations. LCCSS is a narrowing of the central spinal canal causing spinal nerve compression, which can result in painful and chronic symptoms.[@b7-cia-13-1763]--[@b9-cia-13-1763] Previous studies have indicated that morphological parameters, including the spinal canal area, dural sac area, and ligamentum flavum thickness are associated with disc degeneration, aging, and lumbar spinal stenosis.[@b10-cia-13-1763]--[@b12-cia-13-1763] Superior articular process (SAP) hypertrophy is associated with a higher possibility of lumbar foraminal stenosis.[@b13-cia-13-1763] However, no studies have determined the effect of SAP hypertrophy on LCCSS until now. The cross-sectional area (CSA) of the SAP is an important morphological parameter in the identification of facet joint hypertrophy.[@b13-cia-13-1763],[@b14-cia-13-1763] Therefore, to evaluate the connection between LCCSS and hypertrophy of the SAP, we analyzed the superior articular process cross-sectional area (SAPCSA). We hypothesized that the SAPCSA is an important morphological parameter in the diagnosis of LCCSS. We used MRI to compare the SAPCSA between LCCSS patients and normal controls.

Patients and methods
====================

Patients
--------

This study was registered at the Eulji University College of Medicine, Republic of Korea. The Institutional Review Board (IRB) approved and reviewed the research protocol (EMC IRB number 15--94). All participants provided written informed consent to review their radiological images. We retrospectively reviewed the patients who had visited the Catholic Kwandong Spine Center and Pain Clinic between March 2014 and December 2017 and were diagnosed with LCCSS. Patients aged \>60 years were included if they had clinical manifestations compatible with LCCSS (such as low back pain and/or neurogenic intermittent claudication), maximum stenosis occurring at L4--L5, and had MRI within 1 year of the diagnosis that was available for chart review. Patients were excluded if they had a past history of spinal injury or lumbar surgery, congenital spine defect, lumbar spondylolisthesis, complex regional pain syndrome, or history of spinal interventions, such as kyphoplasty or vertebroplasty.

A total of 109 patients were enrolled after the LCCSS diagnosis was confirmed by an experienced, board-certified neuroradiologist. The LCCSS group included 43 (39.4%) men and 66 (60.6%) women with a mean age of 70.81±6.94 years (range, 60--88 years) ([Table 1](#t1-cia-13-1763){ref-type="table"}). The SAPCSA between patients with and without LCCSS was compared with a group of control subjects who had undergone lumbar spine MRI as part of non-symptomatic medical examination. Patients in the control group had no LCCSS-related symptoms. The control group consisted of 120 patients (37 men and 83 women) with a mean age of 68.12±8.13 years (range, 60--87 years) ([Table 1](#t1-cia-13-1763){ref-type="table"}). The SAPCSA in the control group was similarly examined at the L4--L5 facet joint level.

Imaging parameters
------------------

Lumbar spine MRI was performed with 3T Avanto (Siemens Healthcare, Erlangen, Germany) with 3T scanners (Achieva; Philips Healthcare, Amsterdam, the Netherlands). The lumbar MRI examination was conducted using axial T2-weighted images obtained with a slice thickness \<3 mm, 0.9 mm intersection gap, 6,507-ms/120-ms repetition time/echo time, 150×150 field of view, and 256×241 matrix. All MRI data were transferred from the MRI unit to an INFINITT system (INFINITT Healthcare Co., Seoul, Korea).

Image analysis
--------------

The measurement analysis and data collection were performed in a double-blind fashion. The axial T2-weighted MR images in individual patients were acquired at the level of facet joint. A picture archiving and communications system was used to measure the SAPCSA at the L4--L5 facet joint level on MRI. The SAPCSA was measured as the CSA by outlining the SAP at the L4--L5 level ([Figure 1](#f1-cia-13-1763){ref-type="fig"}). To find age-related changes of SAPCSA, we also investigated age-related subgroup analysis.

Statistical analysis
--------------------

The data were expressed as means ± SD. Unpaired *t*-tests were used to compare the SAPCSA between the control and LCCSS groups. *P*-values \<0.05 were considered statistically significant. The correlation between the SAPCSA and age-related changes were analyzed using a one-way ANOVA. The validity of the SAPCSA for diagnosis was estimated using Receiver Operator Characteristic (ROC) curves, optimal cut-off values, area under the curve (AUC), sensitivity, and specificity with 95% CIs. SPSS version 22 for Windows (IBM SPSS, IBM Corp, Armonk, NY, USA) was used for the statistical analysis.

Results
=======

Demographic characteristics were not significantly different between the 2 groups ([Table 1](#t1-cia-13-1763){ref-type="table"}). The average SAPCSA was 96.63±13.37 mm^2^ in the control group, and 123.59±14.18 mm^2^ in the LCCSS one. LCCSS patients had significantly greater SAPCSA (*P*\<0.001) than control subjects ([Table 1](#t1-cia-13-1763){ref-type="table"}). The mean SAPCSA of control group was 96.88±11.60 mm^2^ in subjects aged 60--69 years, 96.43±15.56 mm^2^ in subjects aged 70--79 years, and 95.85±17.37 mm^2^ in subjects in the 80--88 years age group ([Table 2](#t2-cia-13-1763){ref-type="table"}). In the control group, we found no statistically significant relationships between the SAPCSA and age-related changes in the one-way ANOVA (*F*=0.43; df =2; and *P*=0.958). The mean SAPCSA of LCCSS group measured 123.97±14.28 mm^2^ in patients aged 60--69 years, 123.68±14.58 mm^2^ in patients in the 70--79 years age group, and 120.37±11.51 mm^2^ in patients in the 80--88 years age category ([Table 3](#t3-cia-13-1763){ref-type="table"}). In the LCCSS group, we also found no statistically significant relationships between SAPCSA and age-related changes (*F*=0.195; df =2; and *P*=0.823). Regarding the validity of the SAPCSA as predictors of LCCSS, the ROC curve analysis showed that the optimal cut-off point of the SAPCSA was 110.71 mm^2^, with 83.5% sensitivity, 83.3% specificity ([Table 4](#t4-cia-13-1763){ref-type="table"}), and AUC of 0.92 (95% CI: 0.88--0.95) ([Figure 2](#f2-cia-13-1763){ref-type="fig"}).

Discussion
==========

LCCSS is the most common spinal disease in elderly individuals that causes low back or buttock pain and intermittent neurogenic claudication.[@b15-cia-13-1763] LCCSS results from a combination of pathogenic factors, including a decrease in the area of dural sac, hypertrophy of ligamentum flavum, and loss of intervertebral disk height.[@b1-cia-13-1763]--[@b3-cia-13-1763] Facet joint hypertrophy also is a major step in the development of LCCSS.[@b14-cia-13-1763] Previous studies investigated the association between ligamentum flavum, dural sac area, and spinal canal area on MRI and the signs and symptoms of LCCSS. Abbas et al reported that the thickness of ligamentum flavum is gender-independent and age-dependent.[@b10-cia-13-1763] Altinkaya et al found that the ligamentum flavum thickness was correlated with body mass index, spinal level, aging, disc degeneration, and disc herniation.[@b16-cia-13-1763] Ogikubo et al found a significant relationship between shorter walking distances and a smaller dural sac area.[@b12-cia-13-1763] Kim et al reported that a larger dural sac area is associated with a longer subjective walking distance before the onset of claudication.[@b11-cia-13-1763] Lim et al demonstrated that hypertrophy of SAP is a sensitive parameter for the assessment of lumbar foraminal stenosis.[@b13-cia-13-1763] However, there are no previous reports correlating LCCSS and hypertrophy of SAPCSA as a morphologic parameter on MRI. Panjabi et al described the CSA of the superior articular facet.[@b17-cia-13-1763] These CSAs were analyzed in autopsy specimens. Barry et al measured the CSA of the SAP using CT.[@b14-cia-13-1763] In this study, we analyzed the SAPCSA from MRI images, especially visualizing the SAP in the axial T2-weighted MRI. The lumbar MRI provides an enhanced view of the SAP and SAP hypertrophic changes.[@b13-cia-13-1763] Our results demonstrate the association between the SAPCSA and LCCSS. The positive correlation between the SAPCSA and the LCCSS is explained by the increase in SAPCSA associated with the increase in LCCSS. In our study, the best cut-off point for SAPCSA was 110.71 mm^2^, with 83.5% sensitivity, 83.3% specificity, and AUC of 0.92 (95% CI: 0.88--0.95). Our interpretation of these correlations is based on the understanding that the process of SAP hypertrophy begins with mechanical continuous stress during lumbar extension, flexion, and rotation. These stressors exert pressure on the facet joints, which leads to a high degree of abrasion,[@b18-cia-13-1763],[@b19-cia-13-1763] and alter the morphological features of SAP. Bajek et al demonstrated that osteophyte formation in the lumbar spinal canal to stabilize an unstable segment, may result in SAP hypertrophy.[@b20-cia-13-1763] Disc degeneration and herniation may also increase the stress on the morphologic changes in SAP.[@b21-cia-13-1763]

Therefore, our findings suggest that SAPCSA is an objective and accurate morphological parameter for LCCSS prediction. Our study only included individuals aged \>60 years because only minimal changes in cartilage associated with SAP occurred before the age of 45 years, as reported by Lim et al, and that osteoarthritic hypertrophy advances with age.[@b13-cia-13-1763]

The present study had a number of weaknesses. First, we could not compare our SAPCSA with patients' clinical outcomes and symptoms. Second, there may be measurement errors associated with analyzing the SAPCSA on MRI. We measured the SAPCSA in the axial T2 images at the level of the L4--L5 facet joint. However, these axial images may be inhomogeneous due to differences in the cutting angle of the MRI resulting from individual anatomic variations and technical difficulties. A 3.0-mm slice of axial T2-weighted MR image is also thicker than an ideal slice. Third, several methods are known to effectively discriminate LCCSS, such as analysis of cauda equina, morphological grading, and sedimentation signs.[@b22-cia-13-1763]--[@b30-cia-13-1763] However, this study only used SAPCSA measurement. Therefore, our results may be limited regarding measurement of the epidural pressure or morphologic changes. The ultimate weakness of the study is that it was retrospective in nature.

Despite these limitations, this is the first study to document the association of SAPCSA with LCCSS. In our results, the AUC is 0.92 and its accuracy is in the excellent range (0.90--1). Therefore these results are sufficient for SAPCSA to be a senstive parameter to evaluate LCCSS.
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Conclusion
==========

SAPCSA is a sensitive parameter for the diagnosis of LCCSS with an optimal cut-off-point of 110.71 mm^2^, sensitivity of 83.5%, specificity of 83.3%, and AUC of 0.92. We believe that this measurement tool will facilitate the evaluation of patients with LCCSS.

![Measurement of the SAPCSA on T2-weighted MRI at the most stenotic level.\
**Notes:** (**A**) Control group. (**B**) Lumbar central canal spinal stenosis group.\
**Abbreviation:** SAPCSA, superior articular process cross-sectional area.](cia-13-1763Fig1){#f1-cia-13-1763}

![ROC curve of superior articular process cross-sectional area for prediction of lumbar central canal spinal stenosis.\
**Note:** The best cut-off point was 110.71 mm^2^, with sensitivity 83.5%, specificity 83.3%, and AUC 0.92.\
**Abbreviations:** AUC, area under the curve; ROC, receiver operating characteristic.](cia-13-1763Fig2){#f2-cia-13-1763}

###### 

Comparison of the characteristics of control and LCCSS group

  ---------------------------------------------------------------------------------
  Variable               Control group\   LCCSS group\   Statistical significance
                         n=120            n=109          
  ---------------------- ---------------- -------------- --------------------------
  Gender (male/female)   37/83            43/66          NS

  Age (years)            68.12±8.13       70.81±6.94     NS

  SAPCSA (mm^2^)         96.63±13.37      123.59±14.18   *P*\<0.001
  ---------------------------------------------------------------------------------

**Note:** Data represent the mean ± SD or the numbers of patients.

**Abbreviations:** LCCSS, lumbar central canal spinal stenosis; SAPCSA, superior articular process cross-sectional area; NS, not statistically significant (*P*\>0.05).

###### 

Mean SAPCSA of control group by age

  Age distribution (years)   Total (N)
  -------------------------- ---------------------
  60--69                     96.88±11.60 mm (75)
  70--79                     96.43±15.56 mm (29)
  80--88                     95.85±17.37 mm (16)

**Abbreviation:** SAPCSA, superior articular process cross-sectional area.

###### 

Mean SAPCSA of LCCSS group by age

  Age distribution (years)   Total (N)
  -------------------------- ----------------------
  60--69                     123.97±14.28 mm (47)
  70--79                     123.68±14.58 mm (55)
  80--88                     120.37±11.51 mm (7)

**Abbreviations:** LCCSS, lumbar central canal spinal stenosis; SAPCSA, superior articular process cross-sectional area.

###### 

Sensitivity and specificity of each cut-off point of the SAPCSA

  SAPCSA (mm^2^)                                      Sensitivity (%)   Specificity (%)
  --------------------------------------------------- ----------------- -----------------
  77.49                                               100               8.3
  95.28                                               99.1              45.8
  104.69                                              92.7              75.0
  110.71[a](#tfn5-cia-13-1763){ref-type="table-fn"}   83.5              83.3
  114.25                                              71.6              89.2
  122.90                                              48.6              97.5

**Note:**

The best cut-off point on the receiver operating characteristic curve.

**Abbreviation:** SAPCSA, superior articular process cross-sectional area.
